A double-blind crossover trial of isometheptene mucate compound and ergotamine in migraine.
D000588:Amines / Q000009:adverse effects / Q000627:therapeutic use; D003967:Diarrhea / Q000139:chemically induced; D004878:Ergotamine / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008744:Methylamines / Q000009:adverse effects / Q000627:therapeutic use*; D008881:Migraine Disorders / Q000188:drug therapy*; D013566:Sympathomimetics / Q000009:adverse effects / Q000627:therapeutic use*; D014851:Wakefulness / Q000187:drug effects
D000588:Amines; D008744:Methylamines; D013566:Sympathomimetics; D004878:Ergotamine; C008192:isometheptene